Big Pharma uses legal loopholes to block generic drugs, keeping prices high. Product hopping, REMS abuse, and withdrawal of original drugs are antitrust violations that cost consumers billions. Here’s how it works-and who’s fighting back.
Read More
Generic substitution was meant to cut drug costs, but reimbursement systems often block real savings. Learn how MAC lists, PBM spread pricing, and pharmacy margins affect what you pay-and why pharmacists can't always choose the cheapest option.
Read More
Pharmacists support generic substitution to cut costs, but patients often resist due to mistrust, confusion, or fear. Learn the real concerns behind the counter - from NTI drugs to patient education gaps - and how pharmacists are working to build trust.
Read More
Studies show that switching to generic NTI drugs like warfarin, phenytoin, and cyclosporine can lead to dangerous fluctuations in blood levels. While some patients adapt safely, others face seizures, rejection, or bleeding. Monitoring and caution are critical.
Read More